China-Biotics, Inc. ("China-Biotics," the "Company"), a leading manufacturer of biotechnology products and supplements, engages in the research, development, marketing and distribution of probiotics dietary supplements in China. Through its wholly owned subsidiaries, Shanghai Shining Biotechnology Co., Ltd. and Growing Bioengineering (Shanghai) Co. Ltd., the Company develops and produces its proprietary product portfolio. Currently, the retail products are sold OTC through large distributors to pharmacies and supermarkets in Shanghai, Jiangsu, and Zhejiang province. The company currently sells bulk products to institutional customers such as dairy and animal feed producers, as well as pharmaceutical companies. In February 2010, China-Biotics began its commercial production in China's largest probiotics production facility to meet growing demand in China. For more information, please visit http://www.chn-biotics.com .
Safe Harbor Statement
The information in this release contains forward-looking statements which
involve risks and uncertainties, including statements regarding the Company's
capital needs, business strategy and expectations. Any statements contained
herein that are not statements of historical fact may be deemed to be forward-
looking statements, which may be identified by terminology such as "may,"
"should," "will," "expect," "plan," "intend," "anticipate," "believe,"
"estimate," "predict," "potential," "forecast," "project," or "continue," the
negative of such terms or other comparable terminology. Readers should not
rely on forward-looking statements as predictions of future events or results.
Any or all of the Company's forward-looking statements may turn out to be
wrong. They can be affected by inaccurate assumptions, risks and uncertainties
and other factors which could cause actual eve
|SOURCE China-Biotics, Inc.|
Copyright©2010 PR Newswire.
All rights reserved